QR Kod

Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Difloxacin (A-56619) and A-56620, two novel fluoroquinolones, were tested in comparison with ciprofloxacin, cefoxitin, and combined clindamycin and gentamicin in the treatment of experimentally induced intraabdominal abscess associated with Bacteroides fragilis. Difloxacin was found to be as effecti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Thadepalli, H, Gollapudi, S V, Chuah, S K
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 1986
Konular:
Online Erişim:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176483/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3539011/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.4.574
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!